Related Experiment Video
Updated: Mar 16, 2026

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
Published on: January 9, 2020
Minimum information required for a DMET experiment reporting
Judit Kumuthini1, Mamana Mbiyavanga1, Emile R Chimusa1,2
1Centre for Proteomic & Genomic Research, Cape Town, South Africa.
Aim:
To provide pharmacogenomics reporting guidelines, the information and tools required for reporting to public omic databases.
Material & Methods:
For effective DMET data interpretation, sharing, interoperability, reproducibility and reporting, we propose the Minimum Information required for a DMET Experiment (MIDE) reporting.
Results:
MIDE provides reporting guidelines and describes the information required for reporting, data storage and data sharing in the form of XML.
Conclusion:
The MIDE guidelines will benefit the scientific community with pharmacogenomics experiments, including reporting pharmacogenomics data from other technology platforms, with the tools that will ease and automate the generation of such reports using the standardized MIDE XML schema, facilitating the sharing, dissemination, reanalysis of datasets through accessible and transparent pharmacogenomics data reporting.
Related Concept Videos
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect
Measurement of Bioavailability: Pharmacokinetic Methods
Therapeutic Drug Monitoring: Drug Analysis Methods
Pharmacogenetics of Drug Metabolism: Overview
Measurement of Bioavailability: Pharmacodynamic Methods
Dosage Regimens: Partial Pharmacokinetic Parameters

